Stratasys Q4 revenue falls 6.9% to USD 140.0 million

Reuters
03/05
<a href="https://laohu8.com/S/SSYS">Stratasys</a> Q4 revenue falls 6.9% to USD 140.0 million

Stratasys reported Q4 2025 revenue of USD 140.0 million (down 6.9%), with a GAAP net loss of USD 18.9 million and a non-GAAP net income of USD 6.2 million, or USD 0.07 per diluted share. Q4 GAAP gross margin was 36.8% and non-GAAP gross margin was 46.3%; adjusted EBITDA was USD 9.2 million (6.6% of revenue). Operating cash flow in Q4 was USD 4.8 million. For FY 2025, Stratasys posted revenue of USD 551.1 million (down 3.7%), a GAAP net loss of USD 104.3 million (USD 1.28 per diluted share) and non-GAAP net income of USD 12.7 million (USD 0.15 per diluted share). FY 2025 adjusted EBITDA was USD 28.5 million (5.2% of revenue), and operating cash flow was USD 15.1 million. Stratasys ended 2025 with USD 244.5 million in cash, equivalents and short-term deposits and no debt. Management said manufacturing applications represented 37.5% of revenue in 2025 and highlighted progress in aerospace and defense, automotive tooling, dental, and medical applications, supported by continued R&D investment and strategic partnerships. The company guided for FY 2026 revenue of USD 565 million to USD 575 million, adjusted EBITDA of USD 25 million to USD 30 million, and non-GAAP net income of USD 8.0 million to USD 12.5 million, citing an assumed USD 17 million combined adverse impact from exchange rates and tariffs versus 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stratasys Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603050700BIZWIRE_USPR_____20260305_BW568607) on March 05, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10